CIN
MCID: CRV045
MIFTS: 45

Cervical Intraepithelial Neoplasia (CIN)

Categories: Rare diseases

Aliases & Classifications for Cervical Intraepithelial Neoplasia

MalaCards integrated aliases for Cervical Intraepithelial Neoplasia:

Name: Cervical Intraepithelial Neoplasia 54 56 74
Cin 49

Classifications:



External Ids:

UMLS 74 C0206708

Summaries for Cervical Intraepithelial Neoplasia

MalaCards based summary : Cervical Intraepithelial Neoplasia, also known as cin, is related to cervix uteri carcinoma in situ and suppressor of tumorigenicity 3. An important gene associated with Cervical Intraepithelial Neoplasia is CDKN2A (Cyclin Dependent Kinase Inhibitor 2A), and among its related pathways/superpathways are Pathways in cancer and Validated targets of C-MYC transcriptional activation. The drugs Aluminum hydroxide and Bupivacaine have been mentioned in the context of this disorder. Affiliated tissues include testes, cervix and t cells, and related phenotypes are Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435) and mortality/aging

Wikipedia : 77 Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia, is the abnormal growth of... more...

Related Diseases for Cervical Intraepithelial Neoplasia

Diseases related to Cervical Intraepithelial Neoplasia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 125)
# Related Disease Score Top Affiliating Genes
1 cervix uteri carcinoma in situ 33.0 CDKN2A KRT17
2 suppressor of tumorigenicity 3 31.5 CDKN2A FHIT
3 papilloma 31.1 CDKN2A KRT8 ODC1
4 cervical squamous cell carcinoma 30.9 CDKN2A KRT8 MKI67
5 bowenoid papulosis 30.5 CDKN2A TERT
6 cervical cancer 29.8 BIRC5 CDC6 CDKN2A FHIT NME1 TERC
7 colorectal cancer 28.8 BIRC5 CDKN2A FHIT MTHFR NME1 ODC1
8 breast cancer 28.4 BIRC5 FHIT KRT8 MKI67 NME1 ODC1
9 squamous cell carcinoma 10.8
10 squamous cell papilloma 10.7
11 adenocarcinoma 10.5
12 chlamydia 10.5
13 bacterial vaginosis 10.4
14 human immunodeficiency virus infectious disease 10.4
15 immunodeficiency-centromeric instability-facial anomalies syndrome 1 10.4
16 adenocarcinoma in situ 10.4
17 spitz nevus 10.4 CDKN2A MKI67
18 ameloblastic carcinoma 10.4 CDKN2A MKI67
19 endometrial mucinous adenocarcinoma 10.4 CDKN2A MKI67
20 anogenital venereal wart 10.4
21 in situ carcinoma 10.4
22 acral lentiginous melanoma 10.4 CDKN2A TERT
23 inherited bone marrow failure syndromes 10.3 TERC TERT
24 vulva squamous cell carcinoma 10.3 CDKN2A KRT17
25 oral leukoplakia 10.3 CDKN2A MKI67
26 retinoblastoma 10.3
27 herpes simplex 10.3
28 bowen's disease 10.3 KRT17 MKI67
29 megaesophagus 10.3 CDKN2A FHIT
30 dyskeratosis congenita, autosomal dominant 1 10.3 TERC TERT
31 uterus carcinoma in situ 10.3 CDKN2A KRT17
32 nasal cavity cancer 10.3 CDKN2A KRT8
33 infiltrating angiolipoma 10.3 CDKN2A VEGFC
34 cervicitis 10.3
35 revesz syndrome 10.3 TERC TERT
36 cryptogenic cirrhosis 10.3 KRT8 MTHFR
37 pleomorphic liposarcoma 10.3 CDKN2A KRT8
38 soft tissue sarcoma 10.3 MKI67 TERT
39 dyskeratosis congenita autosomal dominant 10.3 TERC TERT
40 necrotizing sialometaplasia 10.3 CDKN2A MKI67
41 leukoplakia 10.2 KRT8 MKI67
42 kidney disease 10.2
43 gastrointestinal stromal tumor 10.2 CDKN2A MKI67 MTHFR
44 anal canal carcinoma 10.2 CDKN2A NME1
45 nasal cavity squamous cell carcinoma 10.2 CDKN2A KRT8
46 benign meningioma 10.2 BIRC5 MKI67 TERT
47 mesenteric vascular occlusion 10.2 MTHFR ODC1
48 tropical calcific pancreatitis 10.2
49 basaloid squamous cell carcinoma 10.2 CDKN2A KRT17 KRT8
50 breast adenoma 10.1 KRT17 ODC1

Graphical network of the top 20 diseases related to Cervical Intraepithelial Neoplasia:



Diseases related to Cervical Intraepithelial Neoplasia

Symptoms & Phenotypes for Cervical Intraepithelial Neoplasia

GenomeRNAi Phenotypes related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

27
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435) GR00104-A-0 8.8 CDC6 MKI67 RBL1

MGI Mouse Phenotypes related to Cervical Intraepithelial Neoplasia:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 mortality/aging MP:0010768 9.7 BIRC5 CDKN2A FHIT KRT17 KRT8 MTHFR
2 digestive/alimentary MP:0005381 9.63 CDKN2A FHIT KRT17 KRT8 RBL1 TERT
3 neoplasm MP:0002006 9.02 CDKN2A FHIT NME1 RBL1 TERT

Drugs & Therapeutics for Cervical Intraepithelial Neoplasia

Drugs for Cervical Intraepithelial Neoplasia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 207)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aluminum hydroxide Approved, Investigational Phase 4,Phase 3 21645-51-2
2
Bupivacaine Approved, Investigational Phase 4 38396-39-3, 2180-92-9 2474
3
Racepinephrine Approved Phase 4,Phase 3,Phase 2 329-65-7 838
4
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2 51-43-4 5816
5
alemtuzumab Approved, Investigational Phase 4 216503-57-0
6 Vaccines Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
7 Immunologic Factors Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
8 Monophosphoryl lipid A Phase 4
9 Anesthetics Phase 4,Phase 3,Phase 2,Not Applicable
10 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1,Not Applicable
11 Neurotransmitter Agents Phase 4,Phase 2,Not Applicable
12 Epinephryl borate Phase 4,Phase 3,Phase 2
13 Bronchodilator Agents Phase 4,Phase 2
14 Adrenergic Agents Phase 4,Phase 2
15 Autonomic Agents Phase 4,Phase 2,Not Applicable
16 Adrenergic Agonists Phase 4,Phase 2
17 Adrenergic beta-Agonists Phase 4,Phase 2
18 Sympathomimetics Phase 4,Phase 2
19 Anesthetics, Local Phase 4,Phase 3,Phase 2
20 Respiratory System Agents Phase 4,Phase 2
21 Vasoconstrictor Agents Phase 4,Phase 2
22 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Not Applicable
23 Mydriatics Phase 4,Phase 2
24 Adrenergic alpha-Agonists Phase 4,Phase 2
25 Anti-Asthmatic Agents Phase 4,Phase 2
26 Hormones Phase 4,Phase 2
27 Estrogens Phase 4
28 Hormone Antagonists Phase 4,Phase 2
29 Estrogens, Conjugated (USP) Phase 4
30 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2
31 Pharmaceutical Solutions Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
32 Antineoplastic Agents, Immunological Phase 4,Phase 2
33
acetic acid Approved Phase 3,Phase 1,Not Applicable,Early Phase 1 64-19-7 176
34
Imiquimod Approved, Investigational Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable 99011-02-6 57469
35
Fluorouracil Approved Phase 3,Phase 1 51-21-8 3385
36
Lidocaine Approved, Vet_approved Phase 3,Phase 2,Not Applicable 137-58-6 3676
37
Eugenol Approved Phase 3 97-53-0 3314
38
Isotretinoin Approved Phase 3 4759-48-2 5282379 5538
39
leucovorin Approved Phase 3,Phase 2,Not Applicable 58-05-9 143 6006
40
Aluminum sulfate Approved Phase 3 10043-01-3
41
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2,Not Applicable 59-30-3 6037
42
3,3'-diindolylmethane Investigational Phase 3 1968-05-4
43
Fenretinide Investigational Phase 3 65646-68-6
44 Adjuvants, Immunologic Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable,Early Phase 1
45 Interferon Inducers Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
46 interferons Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
47 Protective Agents Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1
48 Immunoglobulins Phase 3
49 Antibodies Phase 3
50 Antiviral Agents Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 381)
# Name Status NCT ID Phase Drugs
1 Can Alternative Treatment Have an Impact on Cervical Dysplasia? Unknown status NCT00842738 Phase 4
2 The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP) Unknown status NCT02629510 Phase 4 Tachosil
3 FASTER-Tlalpan Study Unknown status NCT03105856 Phase 4
4 Management of Cervical Intraepithelial Neoplasia Grade 2 Completed NCT00733109 Phase 4
5 V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) Completed NCT01544478 Phase 4
6 Hemodynamic Stability of Bupivacaine With and Without Adrenaline for Paracervical Block for Cervical Conization Completed NCT02368054 Phase 4 Bupivacaine;Adrenaline
7 Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease Completed NCT01034358 Phase 4
8 Effect of Hormone Replacement Therapy on Lupus Activity Completed NCT00392093 Phase 4 Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d
9 Scientific Evaluation of One or Two Doses of the Bivalent or Nonavalent Prophylactic HPV Vaccines Recruiting NCT03180034 Phase 4
10 HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions Recruiting NCT03051516 Phase 4
11 Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study Active, not recruiting NCT03629886 Phase 4
12 CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening (CITRUS Study) Active, not recruiting NCT01895517 Phase 4
13 Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409 Active, not recruiting NCT02255656 Phase 4 alemtuzumab GZ402673
14 Effectiveness of Cervical Screening in HPV Vaccinated Women Enrolling by invitation NCT02149030 Phase 4
15 Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV) Unknown status NCT01095198 Phase 2, Phase 3
16 ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial Completed NCT00941252 Phase 2, Phase 3 Topical imiquimod therapy
17 Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants Completed NCT00128661 Phase 3
18 Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia Completed NCT00212381 Phase 3 di indolylmethane (DIM)
19 Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial Completed NCT02330471 Phase 3
20 Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS) Completed NCT01131312 Phase 3
21 Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix Completed NCT02130323 Phase 2, Phase 3 Imiquimod
22 Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study Completed NCT00929526 Phase 3
23 Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit Completed NCT00237562 Phase 3
24 A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women Completed NCT00000758 Phase 3 Fluorouracil
25 Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED) Completed NCT00092521 Phase 3
26 A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix Completed NCT00264732 Phase 2, Phase 3 Amolimogene;Amolimogene
27 Lidocaine Spray Compared With Submucosal Injection During LEEP: a Randomized Controlled Trial Completed NCT01505920 Phase 3
28 Fenretinide in Treating Patients With Cervical Neoplasia Completed NCT00003075 Phase 3 Fenretinide
29 A Trial of Two Electrosurgical Conizations: Histopathological Analysis of Excision Margins Completed NCT01929993 Phase 3
30 Diindolylmethane in Treating Patients With Abnormal Cervical Cells Completed NCT00462813 Phase 3 oral microencapsulated diindolylmethane
31 A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study Completed NCT03355820 Phase 3
32 Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1 Completed NCT00156026 Phase 3
33 Efficacy Study of Diathermy Cone Biopsy for the Treatment of Cervical Intraepithelial Lesion Completed NCT00995020 Phase 3
34 Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women Completed NCT00337818 Phase 3
35 Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine Completed NCT00316706 Phase 3
36 Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil)(V501-015) Completed NCT00092534 Phase 3
37 Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 Completed NCT00122681 Phase 3
38 Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix Completed NCT02346227 Phase 3 AV2;Placebo
39 Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention Completed NCT01014026 Phase 3
40 Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects Completed NCT00779766 Phase 3
41 Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older Completed NCT00294047 Phase 3
42 A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls Completed NCT02562508 Phase 3
43 A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019) Completed NCT00090220 Phase 3
44 Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors Completed NCT00001073 Phase 3 Isotretinoin
45 Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041) Completed NCT00834106 Phase 3
46 Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System Completed NCT00973362 Phase 3
47 Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) Completed NCT00543543 Phase 3
48 A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018) Completed NCT00092547 Phase 3
49 Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol Recruiting NCT02669459 Phase 3 Imiquimod
50 REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) Recruiting NCT03185013 Phase 3

Search NIH Clinical Center for Cervical Intraepithelial Neoplasia

Genetic Tests for Cervical Intraepithelial Neoplasia

Anatomical Context for Cervical Intraepithelial Neoplasia

MalaCards organs/tissues related to Cervical Intraepithelial Neoplasia:

42
Testes, Cervix, T Cells, Breast, Bone, Kidney, Skin

Publications for Cervical Intraepithelial Neoplasia

Articles related to Cervical Intraepithelial Neoplasia:

(show top 50) (show all 2729)
# Title Authors Year
1
Incidental Detection of Endometriosis with 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in a Patient with Cervical Intraepithelial Neoplasia and Adenomyosis. ( 31040534 )
2019
2
LC/MS-Based Polar Metabolite Profiling Identified Unique Biomarker Signatures for Cervical Cancer and Cervical Intraepithelial Neoplasia Using Global and Targeted Metabolomics. ( 30974861 )
2019
3
Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial. ( 30658933 )
2019
4
Genomic amplification of HPV, h-TERC and c-MYC in liquid-based cytological specimens for screening of cervical intraepithelial neoplasia and cancer. ( 30675277 )
2019
5
Management and treatment of cervical intraepithelial neoplasia in the Netherlands after referral for colposcopy. ( 30687935 )
2019
6
ZNF582 methylation as a potential biomarker to predict cervical intraepithelial neoplasia type III/worse: A meta-analysis of related studies in Chinese population. ( 30732145 )
2019
7
Role of Close Endocervical Margin in Treatment Failure After Cervical Excision for Cervical Intraepithelial Neoplasia: A Retrospective Study. ( 30779593 )
2019
8
Cervical laser vaporization for women with cervical intraepithelial neoplasia-3. ( 30796831 )
2019
9
Prevalence of human papillomavirus and subtype distribution in male partners of women with cervical intraepithelial neoplasia (CIN): a systematic review. ( 30808285 )
2019
10
Incidence and costs of cervical intraepithelial neoplasia in the Korean population. ( 30887758 )
2019
11
Dose-related effectiveness of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia: A Danish nationwide cohort study. ( 30892587 )
2019
12
Systemic adverse events in imiquimod use for cervical intraepithelial neoplasia - A case series. ( 30906696 )
2019
13
Predictors of Absent High-grade Cervical Intraepithelial Neoplasia (CIN) in Loop Electrosurgical Excision Procedure Specimens of Patients with Colposcopic Directed Biopsy-Confirmed High-Grade CIN ( 30912403 )
2019
14
Clinical outcome of high-grade cervical intraepithelial neoplasia during pregnancy: A 10-year experience. ( 30933887 )
2019
15
The Positive Predictive Value of High-Grade Squamous Intraepithelial Lesion on Cytology for the Histological Diagnosis of Cervical Intraepithelial Neoplasia 2 or Higher: A Systematic Review. ( 30947186 )
2019
16
The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up. ( 30955915 )
2019
17
Therapeutic HPV vaccine for cervical intraepithelial neoplasia. ( 30987938 )
2019
18
Spontaneous Regression of Cervical Intraepithelial Neoplasia 2: A Meta-analysis. ( 31055567 )
2019
19
Effectiveness of cold coagulation in treating high-grade cervical intraepithelial neoplasia: the human papillomavirus evidence of cure. ( 31094247 )
2019
20
Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3. ( 31101617 )
2019
21
Incidence of cervical intraepithelial neoplasia in women infected with human immunodeficiency virus (HIV) with no evidence of disease at baseline: Results of a prospective cohort study with up to 6.4 years of follow-up from India. ( 30132840 )
2019
22
Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study. ( 30337414 )
2019
23
Gain of Chromosomal Region 3q26 as a Prognostic Biomarker for High-Grade Cervical Intraepithelial Neoplasia: Literature Overview and Pilot Study. ( 30361910 )
2019
24
Onclarity Human Papillomavirus Extended Genotyping in the Management of Cervical Intraepithelial Neoplasia 2+ Lesions. ( 30371554 )
2019
25
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study. ( 30536370 )
2019
26
Association between oropharyngeal cancers with known HPV and p16 status and cervical intraepithelial neoplasia: a Danish population-based study. ( 30626248 )
2019
27
The CIN-TCP transcription factors promote commitment to differentiation in Arabidopsis leaf pavement cells via both auxin-dependent and independent pathways. ( 30742619 )
2019
28
Evaluation of a Diagnostic Test of Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Urine KIM-1 in Contrast-Induced Nephropathy (CIN). ( 30659575 )
2019
29
Expression of HPV-induced DNA Damage Repair Factors Correlates With CIN Progression. ( 29995652 )
2019
30
Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated and MSI colorectal neoplasia. ( 30716341 )
2019
31
Cohort profile: Children in Need Census (CIN) records of children referred for social care support in England. ( 30798306 )
2019
32
Risk of persistent or recurrent cervical neoplasia in patients with 'pure' adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous neoplasia (cervical intra-epithelial neoplasia grades 2 and 3 (CIN 2/3)): a population-based study. ( 28678394 )
2018
33
Prevalence of human papillomavirus among Wenzhou women diagnosed with cervical intraepithelial neoplasia and cervical cancer. ( 30505342 )
2018
34
Comprehensive genomic variation profiling of cervical intraepithelial neoplasia and cervical cancer identifies potential targets for cervical cancer early warning. ( 30567904 )
2018
35
Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia ( 30485943 )
2018
36
Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer. ( 30353680 )
2018
37
Prevalence and Genotype Distribution of Human Papillomavirus in Invasive Cervical Cancer, Cervical Intraepithelial Neoplasia, and Asymptomatic Women in Southeast China. ( 30402468 )
2018
38
In situ expressions of protein 16 (p16CDKN2A) and transforming growth factor beta-1 in patients with cervical intraepithelial neoplasia and cervical cancer. ( 30059872 )
2018
39
Different amplification patterns of 3q26 and 5p15 regions in cervical intraepithelial neoplasia and cervical cancer. ( 30072014 )
2018
40
Aberrant frequency of TNFR2+ Treg and related cytokines in patients with CIN and cervical cancer. ( 29435163 )
2018
41
Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study. ( 29218720 )
2018
42
Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. ( 29107561 )
2018
43
Joint Guideline of the OEGGG, AGO, AGK and ÖGZ on the Diagnosis and Treatment of Cervical Intraepithelial Neoplasia and Appropriate Procedures When Cytological Specimens Are Unsatisfactory. ( 30651661 )
2018
44
Association between grade of referral smear and high-grade disease among women with biopsy samples showing cervical intraepithelial neoplasia grade 2. ( 29049873 )
2018
45
Association Between Passive Smoking and the Risk of Cervical Intraepithelial Neoplasia 1 in Korean Women. ( 29093300 )
2018
46
High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders. ( 29136403 )
2018
47
Risk of preterm birth in women with cervical intraepithelial neoplasia grade one: a population-based cohort study. ( 29165793 )
2018
48
Depth of Cervical Intraepithelial Neoplasia Grade 3 in Peruvian Women: Implications for Therapeutic Depth of Necrosis. ( 29271853 )
2018
49
Increased Cervical Human Immunodeficiency Virus (HIV) RNA Shedding Among HIV-Infected Women Randomized to Loop Electrosurgical Excision Procedure Compared to Cryotherapy for Cervical Intraepithelial Neoplasia 2/3. ( 29272368 )
2018
50
Safety and tolerance of cidofovir as a 2% gel for local application in high-grade cervical intraepithelial neoplasia: A phase 1 investigation. ( 29319498 )
2018

Variations for Cervical Intraepithelial Neoplasia

Expression for Cervical Intraepithelial Neoplasia

Search GEO for disease gene expression data for Cervical Intraepithelial Neoplasia.

Pathways for Cervical Intraepithelial Neoplasia

Pathways related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 12.08 BIRC5 CDKN2A TERC TERT VEGFC
2 10.83 BIRC5 NME1 ODC1 TERT

GO Terms for Cervical Intraepithelial Neoplasia

Cellular components related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytosol GO:0005829 9.65 BIRC5 CDC6 CDKN2A FHIT KRT17 KRT8
2 intermediate filament GO:0005882 9.43 KRT17 KRT8 NME1
3 telomerase holoenzyme complex GO:0005697 9.16 TERC TERT
4 telomerase catalytic core complex GO:0000333 8.62 TERC TERT

Biological processes related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 DNA biosynthetic process GO:0071897 9.37 TERC TERT
2 cell cycle GO:0007049 9.35 BIRC5 CDC6 CDKN2A MKI67 RBL1
3 nucleotide metabolic process GO:0009117 9.32 FHIT NME1
4 telomere maintenance via telomerase GO:0007004 9.26 TERC TERT
5 replicative senescence GO:0090399 9.16 CDKN2A TERT
6 negative regulation of cellular senescence GO:2000773 8.8 RBL1 TERC TERT

Molecular functions related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 RNA-directed DNA polymerase activity GO:0003964 9.16 TERC TERT
2 telomerase activity GO:0003720 8.96 TERC TERT
3 telomerase RNA reverse transcriptase activity GO:0003721 8.62 TERC TERT
4 protein binding GO:0005515 10.07 BIRC5 CDC6 CDKN2A FHIT KRT17 KRT8

Sources for Cervical Intraepithelial Neoplasia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....